The global 22q11.2 deletion syndrome therapeutics market is experiencing a period of noteworthy growth, driven by factors such as increasing recognition of the condition and the development of novel therapeutic approaches . Researchers are actively investigating a extensive range of therapeutic possibilities , including gene therapy, chemical thera